Please provide your email address to receive an email when new articles are posted on . A study conducted in France found adverse drug reactions were common in patients with chronic kidney disease, ...

Adverse drug reactions (ADRs) encompass a wide spectrum of unintended and harmful responses to medications, with hypersensitivity syndromes representing some of the most severe and potentially ...

Researchers have identified an increasing trend in medicine-related harm leading to hospital admission. Researchers at the University of Liverpool have identified an increasing trend in ...

Medical practitioners need to implement new strategies for decreasing adverse drugs reactions among seniors, conclude the authors of a scientific literature review led by Michael Steinman, MD, a ...

In the United Kingdom, adverse drug reactions (ADRs) to cardiovascular drugs are very common, especially in older and sicker patients. Prevention may include educating patients, monitoring patient ...

Skin rashes can have many different causes, one of which is medications. The symptoms of drug-induced skin reactions can range from a mild itchy rash to more serious reactions, such as widespread ...

A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect ...

Concerned over the widely used life-saving beta blocker drugs causing adverse drug reactions, the government’s Indian Pharmacopoeia Commission (IPC) has issued an alert about the same. An adverse drug ...

Laura A. B. Wilson receives funding from the Australian Research Council. Shinichi Nakagawa receives funding from the Australian Research Council. Compared to men, we know much less about how women ...

A hypersensitivity reaction happens when the immune system mistakenly identifies harmless substances as harmful. There are several types of hypersensitivity reactions, depending on the class of ...

The Indian Pharmacopoeia Commission (IPC), in its latest Drug Safety Alert for September 2025, has reported a safety signal indicating that the antibiotic Erythromycin may be ...